On the Hooked: Ethics, Medicine, and Pharma blog, Howard Brody finished up this week with a bang.
First, he addressed the issue of gifts given to doctors meant to induce them to change their professional decision making. On the heels of a report by Consumers International entitled "Drugs, Doctors and Dinner: How drug companies influence health in the developing world," he noted that some media reports are starting to talk about pharma giving bribes, not just gifts to doctors. Brody acknowledged that he, and many others (yours truly included) have refrained from using such a direct word. But after all, a bribe is "money or any other valuable consideration given or promised with a view to corrupting the behavior of a person, esp. in that person's performance as an athlete, public official, etc." Could a gift given to a physician "corrupt" their behavior? Brody noted that is not an outlandish consideration. He concluded, "So, if the goodies dangled before physicians by the drug companies are in fact bribes, why have we been giving them a free ride for so long and using euphemisms?"
His most recent post dealt with the oft-repeated dogma that the pharmaceutical industry spends more on research than on marketing. He cited a report from the Global Forum for Health Research that suggested all the ways pharma can re-classify what appears to be spending on marketing as spending on research.
Insurance companies cannot dictate which medical devices we prescribe - The diabetes community has been set ablaze after UnitedHealthcare announced an agreement for Medtronic devices to be the “preferred” in-network, durable me...
3 hours ago